Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
118TH CONGRESS
1ST SESSION H. R. 2867
To establish an awareness campaign related to the lethality of fentanyl and
fentanyl-contaminated drugs, to establish a Federal Interagency Work
Group on Fentanyl Contamination of Drugs, and to provide community-
based coalition enhancement grants to mitigate the effects of drug use.
IN THE HOUSE OF REPRESENTATIVES
APRIL 25, 2023
Mr. TRONE (for himself, Mr. ROGERS of Kentucky, Mr. LAMBORN, and Mrs.
PELTOLA) introduced the following bill; which was referred to the Com-
mittee on Energy and Commerce
A BILL
To establish an awareness campaign related to the lethality
of fentanyl and fentanyl-contaminated drugs, to establish
a Federal Interagency Work Group on Fentanyl Con-
tamination of Drugs, and to provide community-based
coalition enhancement grants to mitigate the effects of
drug use.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as ‘‘Bruce’s Law’’.
4
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
2
•HR 2867 IH
SEC. 2. AWARENESS CAMPAIGNS.
1
(a) OPIOID PROGRAM.—Section 102 of the Com-
2
prehensive Addiction and Recovery Act of 2016 (Public
3
Law 114–198) is amended—
4
(1) in the section heading, by inserting ‘‘RE-
5
LATING TO OPIOIDS’’ after ‘‘CAMPAIGNS’’; and
6
(2) in subsection (c)—
7
(A) in paragraph (1), by inserting ‘‘and’’
8
after the semicolon;
9
(B) in paragraph (2)(B), by striking ‘‘;
10
and’’ and inserting a period; and
11
(C) by striking paragraph (3).
12
(b) ADDITIONAL CAMPAIGN.—Title I of the Com-
13
prehensive Addiction and Recovery Act of 2016 (Public
14
Law 114–198) is amended by inserting after section 102
15
the following:
16
‘‘SEC.
102A.
AWARENESS
CAMPAIGN
RELATED
TO
17
LETHALITY OF FENTANYL AND FENTANYL-
18
CONTAMINATED DRUGS.
19
‘‘(a) IN GENERAL.—The Secretary of Health and
20
Human Services, in coordination with the heads of other
21
Federal departments and agencies, shall, as appropriate,
22
through a public awareness campaign, advance the edu-
23
cation and awareness of the public (including school-aged
24
children, youth, parents, first responders, and providers)
25
and other appropriate entities regarding the risk of coun-
26
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
3
•HR 2867 IH
terfeit drugs being contaminated with fentanyl or other
1
synthetic opioids and the lethality and other dangers of
2
synthetic opioids.
3
‘‘(b) TOPICS.—The education and awareness cam-
4
paign under subsection (a) shall address—
5
‘‘(1) the dangers of using drugs which may be
6
contaminated with fentanyl or other synthetic
7
opioids;
8
‘‘(2) the prevention of substance use disorder
9
and use of prescription drugs other than as pre-
10
scribed, including through safe disposal of prescrip-
11
tion medications and other safety precautions; and
12
‘‘(3) the detection of early warning signs of
13
substance use disorder and addiction in school-aged
14
children and youth.
15
‘‘(c) OTHER REQUIREMENTS.—The education and
16
awareness campaign under subsection (a) shall, as appro-
17
priate, take into account any association between the use
18
of prescription drugs other than as prescribed and the use
19
of drugs that can be contaminated by fentanyl or other
20
opioids, including heroin.
21
‘‘(d) DRUG DEFINED.—In this section, the term
22
‘drug’ means—
23
‘‘(1) an illicit drug, such as marijuana, hashish,
24
cocaine
(including
crack
cocaine),
inhalants,
25
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
4
•HR 2867 IH
hallucinogens, heroin, a synthetic opioid, meth-
1
amphetamine or other stimulant;
2
‘‘(2) a counterfeit prescription drug; or
3
‘‘(3) a prescription drug that is sold illegally.
4
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—There
5
are authorized to be appropriated for fiscal years 2024
6
through 2028 such sums as may be necessary to carry
7
out this section.’’.
8
SEC.
3.
FEDERAL
INTERAGENCY
WORK
GROUP
ON
9
FENTANYL CONTAMINATION OF DRUGS.
10
Title I of the Comprehensive Addiction and Recovery
11
Act of 2016 (Public Law 114–198), as amended by section
12
2(b), is further amended by inserting after section 102A
13
the following:
14
‘‘SEC. 102B. FEDERAL INTERAGENCY WORK GROUP ON
15
FENTANYL CONTAMINATION OF DRUGS.
16
‘‘(a) ESTABLISHMENT.—The Secretary of Health
17
and Human Services (referred to in this section as the
18
‘Secretary’) shall establish the Federal Interagency Work
19
Group on Fentanyl Contamination of Drugs (referred to
20
in this section as the ‘Work Group’).
21
‘‘(b) MEMBERSHIP; CONSULTATION.—
22
‘‘(1) COMPOSITION.—Not later than 120 days
23
after the date of enactment of Bruce’s Law, the
24
heads of the Office of National Drug Control Policy,
25
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
5
•HR 2867 IH
the Substance Abuse and Mental Health Services
1
Administration, the Administration for Children and
2
Families, the Centers for Disease Control and Pre-
3
vention, the Department of Justice, the Drug En-
4
forcement Administration, the Department of State,
5
the Department of Education, and other Federal
6
agencies (as determined by the Secretary) shall des-
7
ignate representatives of the respective agency or of-
8
fice to the Work Group.
9
‘‘(2) CONSULTATION.—The Work Group shall
10
consult with—
11
‘‘(A) experts at the State, Tribal, and local
12
levels with relevant backgrounds in reducing,
13
preventing, and responding to drug overdose by
14
fentanyl contamination of drugs;
15
‘‘(B) individuals in recovery from use of
16
fentanyl other than as prescribed or use of
17
other synthetic opioids;
18
‘‘(C) family members of adults who have
19
overdosed by fentanyl-contaminated drugs;
20
‘‘(D) family members of school-aged chil-
21
dren and youth who have overdosed by fentanyl-
22
contaminated drugs;
23
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
6
•HR 2867 IH
‘‘(E) researchers and other experts in the
1
design and implementation of effective drug-re-
2
lated messaging and prevention campaigns; and
3
‘‘(F) technology companies.
4
‘‘(c) DUTIES.—The Work Group shall—
5
‘‘(1) examine all Federal efforts directed to-
6
wards reducing and preventing drug overdose by
7
fentanyl- or other synthetic opioid-contaminated
8
drugs;
9
‘‘(2) identify strategies, resources, and supports
10
to improve State, Tribal, and local responses to over-
11
dose by fentanyl- or other synthetic opioid-contami-
12
nated drugs;
13
‘‘(3) make recommendations to Congress for
14
improving Federal programs and efforts and coordi-
15
nation across such programs and efforts to reduce
16
and prevent drug overdose by fentanyl- or other syn-
17
thetic opioid-contaminated drugs; and
18
‘‘(4) make recommendations for educating
19
youth on the dangers of drugs contaminated by
20
fentanyl or other synthetic opioids.
21
‘‘(d) ANNUAL REPORT TO SECRETARY.—The Work
22
Group shall annually prepare and submit to the Secretary,
23
the Committee on Health, Education, Labor, and Pen-
24
sions of the Senate, and the Committee on Education and
25
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
7
•HR 2867 IH
the Workforce and the Committee on Energy and Com-
1
merce of the House of Representatives, a report on the
2
activities carried out by the Work Group under subsection
3
(c), including recommendations to reduce and prevent
4
drug overdose by fentanyl or other synthetic opioid con-
5
tamination of drugs, in all populations, and specifically
6
among youth at risk for substance use disorder and use
7
of drugs other than as prescribed.’’.
8
SEC. 4. COMMUNITY-BASED COALITION ENHANCEMENT
9
GRANTS TO ADDRESS LOCAL DRUG CRISES.
10
Section 103(i) of the Comprehensive Addiction and
11
Recovery Act of 2016 (21 U.S.C. 1536(i)) is amended by
12
striking ‘‘2017 through 2021’’ and inserting ‘‘2024
13
through 2028’’.
14
SEC. 5. COMMUNITY-BASED COALITION ENHANCEMENT
15
GRANTS TO EDUCATE YOUTH ON THE RISKS
16
OF DRUGS CONTAMINATED WITH FENTANYL
17
OR OTHER SYNTHETIC OPIOIDS.
18
Title I of the Comprehensive Addiction and Recovery
19
Act of 2016 (Public Law 114–198) is amended by insert-
20
ing after section 103 (21 U.S.C. 1536) the following:
21
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
8
•HR 2867 IH
‘‘SEC. 103A. COMMUNITY-BASED COALITION ENHANCEMENT
1
GRANTS TO EDUCATE YOUTH ON THE RISKS
2
OF DRUGS CONTAMINATED WITH FENTANYL
3
OR OTHER SYNTHETIC OPIOIDS.
4
‘‘(a) PROGRAM AUTHORIZED.—The Director of the
5
Office of National Drug Control Policy (referred to in this
6
section as the ‘Director’), in coordination with the Direc-
7
tor of the Centers for Disease Control and Prevention,
8
may make grants to eligible entities to implement edu-
9
cation of the public on the dangers of contamination of
10
drugs with fentanyl or other synthetic opioids.
11
‘‘(b) APPLICATION.—
12
‘‘(1) IN GENERAL.—An eligible entity seeking a
13
grant under this section shall submit an application
14
to the Director at such time, in such manner, and
15
accompanied by such information as the Director
16
may require.
17
‘‘(2) CRITERIA.—As part of an application for
18
a grant under this section, the Director shall require
19
an eligible entity to submit a detailed, comprehen-
20
sive, multisector plan for addressing the implementa-
21
tion of an evidence-based public education campaign
22
on the dangers of drugs contaminated with fentanyl
23
or other synthetic opioids, with a specific consider-
24
ation given to education focused on youth at in-
25
creased risk for developing a substance use disorder.
26
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
9
•HR 2867 IH
‘‘(3) ELIGIBLE ENTITIES.—For purposes of this
1
section, the term ‘eligible entity’ means an entity
2
that—
3
‘‘(A) has documented, using local data,
4
rates of drug overdose related to fentanyl or
5
other synthetic opioids at levels that are signifi-
6
cant, as determined by the Director; and
7
‘‘(B) has received a grant under the Drug-
8
Free Communities Act of 1997.
9
‘‘(c) USE OF FUNDS.—An eligible entity shall use a
10
grant received under this section—
11
‘‘(1) for programs designed to implement com-
12
prehensive community-wide prevention strategies to
13
address the dangers of drugs contaminated with
14
fentanyl or other synthetic opioids, in the area
15
served by the eligible entity, in accordance with the
16
plan submitted under subsection (b)(2);
17
‘‘(2) to obtain specialized training and technical
18
assistance from the organization funded under sec-
19
tion 4 of Public Law 107–82 (21 U.S.C. 1521 note);
20
and
21
‘‘(3) for programs designed to implement com-
22
prehensive community-wide strategies to address the
23
dangers of drugs contaminated with fentanyl or
24
other synthetic opioids in the community.
25
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
10
•HR 2867 IH
‘‘(d) SUPPLEMENT NOT SUPPLANT.—An eligible en-
1
tity shall use Federal funds received under this section
2
only to supplement the funds that would, in the absence
3
of those Federal funds, be made available from other Fed-
4
eral and non-Federal sources for the activities described
5
in this section, and not to supplant those funds.
6
‘‘(e) EVALUATION.—A grant under this section shall
7
be subject to the same evaluation requirements and proce-
8
dures as the evaluation requirements and procedures im-
9
posed on the recipient of a grant under the Drug-Free
10
Communities Act of 1997, and shall also include an eval-
11
uation of the effectiveness at reducing the use of illicit
12
fentanyl or other synthetic opioids.
13
‘‘(f) LIMITATION ON ADMINISTRATIVE EXPENSES.—
14
Not more than 12 percent of the amounts made available
15
to carry out this section for a fiscal year may be used
16
to pay for administrative expenses.
17
‘‘(g) DELEGATION AUTHORITY.—The Director may
18
enter into an interagency agreement with the Director of
19
the Centers for Disease Control and Prevention to dele-
20
gate authority for the execution of grants and for such
21
other activities, as the Director determines necessary to
22
carry out this section.
23
‘‘(h) DEFINITION.—In this section, the term ‘drug’
24
has the meaning given such term in section 102A.
25
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
11
•HR 2867 IH
‘‘(i) AUTHORIZATION OF APPROPRIATIONS.—For the
1
purpose of carrying out this section, there are authorized
2
to be appropriated such sums as may be necessary for
3
each of fiscal years 2024 through 2028.’’.
4
Æ
VerDate Sep 11 2014
20:02 May 04, 2023
Jkt 039200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6301
E:\BILLS\H2867.IH
H2867
pbinns on DSKJLVW7X2PROD with $$_JOB
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.